Latest
Professor Bruce Robinson appointed as MST’s Senior Biotech & Medical Adviser
14 September 2026
Press
News
Stay ahead with timely financial insights.
30 January 2023
How long can electric vehicle transition keep driving ASX Lithium stocks?
22 December 2022
MST Financial Equity Markets Wrap Up
06 December 2022
MST Financial hosts ASX-Listed diagnostics forum
30 November 2022
Life360 (360.ASX) chases $50m equity via MST
29 November 2022
Online battle gets serious as Amazon shifts gears
24 November 2022
MST Financial to host ASX-listed Biotech Forum
27 September 2022
Adherium (ADR.ASX) secures $13.5m in private placement
21 September 2022
The market’s infatuation with owning unprofitable stocks won’t die
29 August 2022
CardieX (CDX.ASX) completes $4.33 million placement, poised to launch SPP to accelerate growth initiatives
Page 14 of 176
Research
OverviewAnalystsStock CoverageLog in
Services
Capital MarketsAdvisorySales & TradingIncome
Products
Sandstone Income SMAMonthly Income FundAustralian Bond FundIndividually Managed Accounts
Resources
AboutNewsContact

All material on this website has been prepared by MST Financial Services Pty Limited (ABN 54 617 475 180, AFSL 500 557) for general informational purposes only and is not a solicitation of any offer to buy or sell any financial instrument or to participate in any trading strategy. Unless otherwise stated, the material presented on this site is not a research report as defined under ASIC guidance. For wholesale clients only. This material is only prepared for wholesale clients pursuant to section 761G(7) of the Corporations Act (Commonwealth). Please also refer to MST's Privacy Policy, Terms of Use and Financial Services Guide.

Some of the products referred to on this website are issued by Equity Trustees Limited (ABN 46 004 031 298, AFSL 240975), the Responsible Entity of the funds. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a company listed on the ASX (ASX: EQT). Before making any investment decision, you should carefully review the relevant disclosure documents, including the Product Disclosure Statement (PDS), Reference Guide (RG), and Target Market Determination (TMD), available from Equity Trustees. For MST Individually Managed Accounts (IMAs), please refer to the Information Memorandum. MST does not warrant the accuracy or completeness of the information provided and disclaims all liability for any errors or omissions, to the extent permitted by law. Past performance is not a reliable indicator of future performance.

© 2026 MST Financial | All rights reserved | Designed by Comma
Privacy PolicyTerms of UseResearch DisclosuresFinancial Services Guide